The Board of Directors of Entero Healthcare Solutions Limited, in its meeting held on May 25, 2026, approved the audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026. The company reported a revenue from operations of ₹780 crores for the quarter ended March 31, 2026, compared to ₹1,706.52 crores in the previous quarter (Q3 FY26) and ₹1,359.00 crores in the corresponding quarter last year (Q4 FY25). The net profit for the current quarter stood at ₹XX crores.

Entero Healthcare Solutions Limited is a rapidly growing healthcare products distribution platform in India, which offers demand generation and fulfillment services to manufacturers. The company promotes product brands to healthcare professionals and facilitates distribution through e-commerce and various channels, including pharmacies, hospitals, and clinics. The company was founded in 2018 by Prabhat Agrawal to create an organized, pan-India, technology-driven, and integrated healthcare products distribution platform. Key investors in the company include OrbiMed Asia III Mauritius Limited (holding 38.01%), ICICI Prudential Value Fund (4.82%), and Invesco India Aggressive Hybrid Fund (4.35%).